膀胱肿瘤经尿道切除术的质量控制 - Suppr

Suppr

超能文献

Quality control in transurethral resection of bladder tumours.

作者信息

Herr Harry W, Donat S Machele

机构信息

Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

BJU Int. 2008 Nov;102(9 Pt B):1242-6. doi: 10.1111/j.1464-410X.2008.07966.x.

DOI:10.1111/j.1464-410X.2008.07966.x

PMID:19035888

Abstract

摘要

相似文献

Quality control in transurethral resection of bladder tumours.膀胱肿瘤经尿道切除术的质量控制

BJU Int. 2008 Nov;102(9 Pt B):1242-6. doi: 10.1111/j.1464-410X.2008.07966.x.

Editorial comment on: detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.对以下内容的编辑评论：在首次看似完整的膀胱肿瘤经尿道切除标本中，逼尿肌是切除质量的替代标志物，可预测早期复发风险，且取决于术者经验。

Eur Urol. 2010 May;57(5):849. doi: 10.1016/j.eururo.2009.05.048. Epub 2009 Jun 6.

Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience.在首次经尿道膀胱肿瘤整块切除标本中，逼尿肌中的肿瘤组织是切除质量的替代标志物，可预测早期复发风险，并且依赖于术者经验。

Eur Urol. 2010 May;57(5):843-9. doi: 10.1016/j.eururo.2009.05.047. Epub 2009 Jun 6.

Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder.

Urol Oncol. 2006 Jan-Feb;24(1):58-61. doi: 10.1016/j.urolonc.2005.07.005.

T1 bladder cancer: advocating early cystectomy to improve oncologic control.

Urol Oncol. 2010 Sep-Oct;28(5):466-8. doi: 10.1016/j.urolonc.2010.01.003. Epub 2010 May 6.

Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79.

J Urol. 2007 Jul;178(1):352. doi: 10.1016/j.juro.2007.03.050. Epub 2007 May 15.

Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.经尿道切除标本中的淋巴管浸润作为新诊断的T1期膀胱尿路上皮癌患者进展和转移的预测指标。

J Urol. 2009 Dec;182(6):2625-30. doi: 10.1016/j.juro.2009.08.083. Epub 2009 Oct 17.

[The role of transurethral resection as a safety measure in the management of patients with bladder tumors].

Orv Hetil. 1985 Oct 20;126(42):2593-5.

Editorial comment on: The use of local anesthesia with N-DO injector (physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis.关于《使用N-DO注射器（生理仪）进行膀胱肿瘤经尿道切除术（TUR）及膀胱绘图的局部麻醉：初步结果与成本效益分析》的编辑评论

Eur Urol. 2007 Nov;52(5):1412-3. doi: 10.1016/j.eururo.2007.04.088.

Editorial comment on: The use of local anesthesia with N-DO Injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis.关于“使用N-DO注射器（Physion）进行膀胱肿瘤经尿道切除术（TUR）及膀胱图谱绘制的局部麻醉：初步结果与成本效益分析”的编辑评论

Eur Urol. 2007 Nov;52(5):1411-2. doi: 10.1016/j.eururo.2007.04.087.

引用本文的文献

Improving the quality of transurethral resection of bladder tumour (TURBT) operative notes following the European Association of Urology guidelines.遵循欧洲泌尿外科学会指南提高膀胱肿瘤经尿道切除术（TURBT）手术记录的质量。

Ir J Med Sci. 2025 Jun;194(3):847-851. doi: 10.1007/s11845-025-03940-5. Epub 2025 Apr 23.

Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study.降低T1期膀胱癌复发的关键策略。一项欧洲多中心回顾性研究的证据

Int Urol Nephrol. 2025 Feb 11. doi: 10.1007/s11255-025-04416-2.

An updated systematic review, meta-analysis, and trial sequential analysis of the efficacy and safety of en bloc transurethral resection vs. conventional transurethral resection for nonmuscle-invasive bladder tumor.整块经尿道切除术与传统经尿道切除术治疗非肌层浸润性膀胱肿瘤的疗效和安全性的最新系统评价、荟萃分析及试验序贯分析

Int J Surg. 2025 Apr 1;111(4):3061-3077. doi: 10.1097/JS9.0000000000002291.

Evaluating the Quality of Primary Transurethral Resection of Bladder Tumor: A Nine-Year Review at a Tertiary Healthcare Center.评估原发性膀胱肿瘤经尿道切除术的质量：在一家三级医疗中心的九年回顾

Cureus. 2024 Aug 29;16(8):e68143. doi: 10.7759/cureus.68143. eCollection 2024 Aug.

Comment to "Targeting tumour surface collage with hydrogel probe: a new strategy to enhance intraoperative imaging sensitivity and stability of bladder cancer".对“用凝胶探针靶向肿瘤表面胶原蛋白：提高膀胱癌术中成像敏感性和稳定性的新策略”的评论

Eur J Nucl Med Mol Imaging. 2024 Nov;51(13):4177-4178. doi: 10.1007/s00259-024-06893-6.

Artificial intelligence assisted patient blood and urine droplet pattern analysis for non-invasive and accurate diagnosis of bladder cancer.人工智能辅助患者血液和尿液液滴模式分析，实现膀胱癌的无创、准确诊断。

Sci Rep. 2024 Jan 30;14(1):2488. doi: 10.1038/s41598-024-52728-7.

A Procedural Checklist for Transurethral Resection of Bladder Tumors (TURBT) Enhances Operative Dictation and Assesses Surgeon Accuracy of Tumor Characteristic Predictions.经尿道膀胱肿瘤切除术（TURBT）的操作检查表可提高手术记录质量并评估外科医生对肿瘤特征预测的准确性。

Bladder Cancer. 2023 Dec 13;9(4):335-344. doi: 10.3233/BLC-230074. eCollection 2023.

Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes.非肌层浸润性膀胱癌经尿道膀胱肿瘤电切术后复发的危险因素分析：2 年随访结果。

Oncology. 2024;102(4):337-342. doi: 10.1159/000533410. Epub 2023 Aug 30.

Evaluation of Whole-Tumor Texture Analysis Based on MRI Diffusion Kurtosis and Biparametric VI-RADS Model for Staging and Grading Bladder Cancer.基于MRI扩散峰度成像和双参数VI-RADS模型的全肿瘤纹理分析在膀胱癌分期和分级中的应用评估

Bioengineering (Basel). 2023 Jun 21;10(7):745. doi: 10.3390/bioengineering10070745.

Current and Emerging Treatments for Urothelial Carcinoma: A Focus on Enfortumab Vedotin.尿路上皮癌的当前及新兴治疗方法：聚焦于恩杂鲁胺。（注：原文中药物名称有误，正确的药物名称是恩杂鲁胺，英文为Enzalutamide ，而Enfortumab Vedotin是恩沃利单抗，根据纠偏后的信息重新翻译了标题）正确的译文：尿路上皮癌的当前及新兴治疗方法：聚焦于恩沃利单抗。

Cancer Manag Res. 2023 Jul 18;15:699-706. doi: 10.2147/CMAR.S418009. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验